TUMORMARKERSㅣTHYROIDㅣFERTILITYㅣENDOCRINOLOGYㅣDIABETESㅣANEMIAㅣPHOSPHOCALCIC AXISㅣCARDIAC MARKERSㅣHEPATITISㅣOTHERS
 

PRODUCT

REF.
(No of tubes)

METHOD
SEPARATION

TRACER
ACT (kBq)

STANDARD
(No and Range)

CONTROLS

SAMPLE
(Vol. and type)

INCUBATIONS
(Time/T°)

SHELF-LIFE
(Labelling
periodicity)

COMMENTS

ESTRADIOL

ESTR-CTRIA
(96)

RIA Competition
Coated tubes

¹²⁵ I
93

7
0 → 18330 pmol/l

0

100μl
Serum, Plasma

1 h 30 or 2 h 30
RT

6 weeks
(every 4 weeks)

ESTRADIOL
ULTRA
SENSITIVE

ESTR-US-CT
(100)

RIA Competition
Coated tubes

¹²⁵ I
85

6
0 → 2000 pmol/l

0

200μl
Serum, Plasma

2 x 1 h
37°C

6 weeks
(every 4 weeks)

Sensitivity = 5 pmol/l

hCG

OCPM03-HCG
(100)

IRMA
Coated tubes

¹²⁵ I
300

8
0 → 1000mlU/ml

1

100μl
Serum, Plasma,
urine

30' + 60'
RT

9 weeks
(every 6 weeks)

Monoclonal antibodies Special protocol for qualitative assay on serum and urine

17OH
PROGES
TERONE

OHP-CT
(100)

RIA Competition
Coated tubes

¹²⁵ I
104

7
0 → 75.7 nmol/l

0

25μl
Serum, Plasma

2 h 30
RT

6 weeks
(every 4 weeks)

PROGES
TERONE

PROG-CTRIA
(96)

RIA Competition
Coated tubes

¹²⁵ I
89

7
0 → 191nmol/l

0

50μl
Serum, Plasma

2 h
RT

6 weeks
(every 4 weeks)

PROL
ACTIN

OCFP07-PROL
(100)

IRMA
Coated tubes

¹²⁵ I
300

6
0 → 6000μlU/ml

1

50μl
Serum, Plasma

2 h x 30'
RT

9 weeks
(every 6 weeks)

Monoclonal antibodies
WHO 3rd IRP 84/500

TESTOS
TERONE

TESTO-CT2
(100)

RIA Competition
Coated tubes

¹²⁵ I
200

6
0 → 50nmol/l

0

25μl
Serum, Plasma

1 h
37°C

10 weeks
(every 4 weeks)